Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 (HHLA2) is a Novel Immune Checkpoint Protein in Lung Cancer which Predicts Survival. This evidence concerns the gene HHLA2 and lung cancer.